After a tough few years, 2011 is shaping up quite nicely for shareholders of Quebec City's Aeterna Zentaris (TSX:AEZ). Today, nearly eight years … [Read more...] about Eight is Enough for AEterna Zentaris; granted European patent for Perifosine
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
Things are changing quickly in the world of fish-farming. For proof you need look no further than the man voted "Canada's most trusted Canadian" in a … [Read more...] about 5 Questions with Richard Buchanan of Agrimarine (TSXV:FSH)
Shareholders of Toronto's Bioexx (TSX:BXI) are having the kind of day that has become all too familiar to them. The stock, which was down more than … [Read more...] about Is Bioexx ready to rebound?
A step closer. Quebec City's Medicago (TSX:MDG) today announced results from a phase I human trial that showed its H1N1 vaccine is safe. A hundred … [Read more...] about Medicago: Life in the Fast Lane
Shares of Resverlogix (TSX:RVX) are sliding today after the company announced it will raise $12.6 million. The Calgary based biotech will sell seven … [Read more...] about Resverlogix Slides on Financing News
Ask investors to play the word association game with Noveko (TSX:EKO) and it won't be long before the words swine flu show up. The Montreal company … [Read more...] about Is Noveko set to cash in on the “green building” movement?
When hospital staff at B.C.'s Royal Columbian Hospital were forced to treat overflow emergency room patients in a crammed Tim Horton's donut shop one … [Read more...] about Investors betting Biosign’s chances of success far from remote
Quebec City's AEterna Zentaris (TSX:AEZ), the developer of oncological and endocrine therapies, is really testing the notion of sector negativity … [Read more...] about Should AEterna Zentaris be rising or falling on Japan woes?
To say it has been a bumpy road for MediPattern (TSXV:MKI) investors of late might be an understatement. The Toronto based company, which designs … [Read more...] about Investors Visualize Success for MediPattern
Last year, Canada became the first country to place an outright ban on bisephenol A, a toxic substance better know as BPA. Canada joined the European … [Read more...] about Functional Technologies rises on new food safety concerns